Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hardy

Showing results (441-450 of 504) with videos related to

Pageof 51
Sort By:
The British Journal of Radiology|December 1, 1992
99Tcm-Technegas and krypton-81m ventilation scintigraphy: a comparison in known respiratory diseaseJ M James, J J Lloyd, B C Leahy, et al.
International Archives of Allergy and Applied Immunology|January 1, 1985
Relationship between mediator release from human lung mast cells in vitro and in vivoS T Holgate, R C Benyon, P H Howarth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancerJ P Stevenson, M Redlinger, L A Kluijtmans, et al.
Physical Review Letters|April 7, 2010
QEC values of the superallowed beta emitters 34Cl and 38KmT Eronen, V-V Elomaa, J Hakala, et al.
Journal of the American College of Cardiology|December 19, 1998
New real-time interactive cardiac magnetic resonance imaging system complements echocardiographyP C Yang, A B Kerr, A C Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2024
A DNA condensation code for linker histonesMatthew Watson, Dilyara Sabirova, Megan C Hardy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO groupS Camilleri-Broët, A C Hardy-Bessard, A Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2009
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLEC de la Fouchardière, R Largillier, Y Goubely, et al.
Genomics|March 20, 1995
Analysis of the structural integrity of YACs comprising human immunoglobulin genes in yeast and in embryonic stem cellsM J Mendez, H Abderrahim, M Noguchi, et al.
Gynecologic Oncology|February 24, 2009
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trialJ E Kurtz, A-C Hardy-Bessard, M Deslandres, et al.
Pageof 51

Showing results (441-450 of 504) with videos related to

Sort By:
Pageof 51
The British Journal of Radiology|December 1, 1992
99Tcm-Technegas and krypton-81m ventilation scintigraphy: a comparison in known respiratory diseaseJ M James, J J Lloyd, B C Leahy, et al.
International Archives of Allergy and Applied Immunology|January 1, 1985
Relationship between mediator release from human lung mast cells in vitro and in vivoS T Holgate, R C Benyon, P H Howarth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Phase I clinical and pharmacogenetic trial of irinotecan and raltitrexed administered every 21 days to patients with cancerJ P Stevenson, M Redlinger, L A Kluijtmans, et al.
Physical Review Letters|April 7, 2010
QEC values of the superallowed beta emitters 34Cl and 38KmT Eronen, V-V Elomaa, J Hakala, et al.
Journal of the American College of Cardiology|December 19, 1998
New real-time interactive cardiac magnetic resonance imaging system complements echocardiographyP C Yang, A B Kerr, A C Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2024
A DNA condensation code for linker histonesMatthew Watson, Dilyara Sabirova, Megan C Hardy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO groupS Camilleri-Broët, A C Hardy-Bessard, A Le Tourneau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2009
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLEC de la Fouchardière, R Largillier, Y Goubely, et al.
Genomics|March 20, 1995
Analysis of the structural integrity of YACs comprising human immunoglobulin genes in yeast and in embryonic stem cellsM J Mendez, H Abderrahim, M Noguchi, et al.
Gynecologic Oncology|February 24, 2009
Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trialJ E Kurtz, A-C Hardy-Bessard, M Deslandres, et al.
Pageof 51